Labs and test makers say they are confused about what if anything Medicare contractors are paying for various molecular diagnostics including next-generation sequencing following CMS' recent release of codes and pricing for 2015. Meanwhile, industry groups are anxious that the agency has yet to issue a proposed rule to implement broader statutory changes to diagnostic price-setting.
The Medicare reimbursement landscape for next-generation sequencing and other molecular diagnostics remain murky, labs and test makers say, following CMS' recent publication of its proposed 2015 clinical laboratory fee schedule test codes and preliminary payment determinations.
At the end of May, the agency published an excel spreadsheet
Without change, the implementation of the MDR and IVDR could hit another wall.
Dexcom introduced a new AI-powered smart food logging feature in its Stelo and G7 platforms. This tool allows users to generate detailed meal descriptions from photos and analyzes the glycemic impact of those meals.
Evolution of the MHRA and its offering to medtechs continues, with the hunt for a visionary chief medical and scientific officer and release of outline plans on early access to innovative devices, building on IDAP learnings.
